Sanjivani Paranteral Reports Strong Financial Growth and Sales Surge in May 2025 Results

Sanjivani Paranteral, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently released its financial results for the quarter ending March 2025. The results, declared on May 27, 2025, indicate a notable shift in the company's financial standing. The Profit After Tax (PAT) for the latest six months stands at Rs 4.09 crore, reflecting a year-on-year growth of 40.55%. This positive trend in PAT suggests a strengthening financial position for the company. Additionally, net sales for the quarter reached Rs 18.18 crore, marking the highest figure recorded in the last five quarters. This upward movement in sales further supports the favorable outlook for Sanjivani Paranteral. In light of these developments, the company has experienced an adjustment in its evaluation, with its score rising to 11 from 4 over the past three months. This revision highlights the positive trajectory of Sanjivani Paranteral's financial metrics. For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.